| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |